Impact of the high tyrosine fraction in complementarity determining regions: measured and predicted effects of radioiodination on IgG immunoreactivity

Bolton, 1973, The labeling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent, Biochem. J., 133, 529, 10.1042/bj1330529 Brechbiel, 1992, Synthesis of C-functionalized trans-cyclohexyldiethylenetriaminepentaacetic acids for labelling of monoclonal antibodies with the bismuth-212 α-particle emitter, J. Chem. Soc. Perkin Trans., 1, 1173, 10.1039/P19920001173 Camera, 1994, Evaluation of the serum stability and in vivo biodistribution of CHXA-DTPA and other ligands for yttrium labeling of monoclonal antibodies, J. nucl. Med., 35, 882 Caron, 1992, Biological and immunological features of humanized M195 (anti-CD33) monoclonal antibodies, Cancer Res., 52, 6761 Caron, 1994, A phase 1B trial of humanized monoclonal antibody M195 (antiCD33) in myeloid leukemia: Specific targeting without immunogenicity, Blood, 83, 1760, 10.1182/blood.V83.7.1760.1760 Co, 1992, Chimeric and humanized antibodies with specificity for the CD33 antigen, J. Immunol., 148, 1149, 10.4049/jimmunol.148.4.1149 Co, 1991, Humanized antibodies for antiviral therapy, 88, 2869 Co, 1994, A humanized antibody specific for the platelet integrin gpIIbIIIa, J. Immunol., 152, 2968, 10.4049/jimmunol.152.6.2968 Ferens, 1984, High-level iodination of monoclonal antibody fragments for radiotherapy, J. nucl. Med., 25, 367 Finn R. D., Nikula T., Macapinlac H., Kothari P. and Scheinberg D. A. Clinical support: No longer pure radiochemistry. In The Proceedings of the Symposium on Applications of Nuclear Chemistry (Edited by Mc Harris). American Chemical Society, San Diego, in press. Fracker, 1978, Protein and cell membrane iodinations with a sparingly soluble chloramide 1,3,4,6-tetrachloro-3α, 6α-diphenylglycoluril, Biochem. biophys. Res. Commun., 80, 849, 10.1016/0006-291X(78)91322-0 Geerlings, 1993, The feasibility of 225Ac as a source of α-particles in radioimmunotheraphy, Nucl. Med. Commun., 14, 121, 10.1097/00006231-199302000-00009 Griffiths, 1991, Direct radiolabeling of monoclonal antibodies with generator-produced rhenium-188 for radioimmunotheraphy: Labeling and animal biodistribution studies, Cancer Res., 51, 4594 Harlow, 1988, Digesting antibodies with papain to isolate Fab fragments, 628 Hird, 1993, Adjuvant therapy of ovarian cancer with radioactive monoclonal antibody, Br. J. Cancer, 68, 403, 10.1038/bjc.1993.349 Hnatowich, 1983, Radioactive labeling of antibody: A simple and efficient method, Science, 220, 613, 10.1126/science.6836304 Huneke, 1992, Effective a-particle-mediated radioimmunotheraphy of murine leukemia, Cancer Res., 52, 5818 Hunter, 1962, Preparation of iodine-131 labelled human growth hormones of high specific activity, Nature, 194, 495, 10.1038/194495a0 Jacobs, 1993, A phase I trial of a rhenium 186-labeld monoclonal antibody administered intraperitoneally in ovarian carcinoma: Toxicity and clinical response, Obstet. Gynecol., 82, 586, 10.1097/00006250-199310000-00022 John, 1993, Rhenium-186-labeld monoclonal antibodies for radioimmunotherapy: preparation and evaluation, J. nucl. Med., 34, 260 Juric J. G. and Scheinberg D. A. Monoclonal antibody therapy of myeloid leukemias. Princ. Prac. Oncol. in press. Kabat, 1991 Langmuir, 1990, Iodine-125-NLRU-10 kinetic studies and bismuth-212-NRLU-10 toxity in LS174T multicell spheroids, J. nucl. Med., 31, 1527 Larson, 1986, A tentative biological model for the localization of radioabelled antibody in tumor: The importance of immunoreactivity, Nucl. Med. Biol., 13, 393 Larson, 1984, Radioimmunodetection and radioimmunotherapy, Cancer Invest., 2, 363, 10.3109/07357908409040313 Macklis, 1988, Radioimmunotheraphy with alphaparticle-emitting immunoconjugates, Science, 240, 1024, 10.1126/science.2897133 Maisano, 1992, Coupling of DTPA to proteins: A critical analysis of the cyclic dianhydride method in the case of insulin modification, Bioconjugate Chem., 3, 212, 10.1021/bc00015a002 Marchalonis, 1969, An enzymic method for the tracer iodination of immunoglobulins and other proteins, Biochem. J., 113, 299, 10.1042/bj1130299 Matzku, 1987, Iodination of monoclonal IgG antibodies at a sub-stoichiometric level: Immunoreactivity changes related to the site of iodine incorporation, Nucl. Med. Biol., 14, 451 Nikula, 1995, A rapid, single vessel method for preparation of clinical grade ligand conjugated monoclonal antibodies, Nucl. Med. Biol., 10.1016/0969-8051(94)00126-5 Nikula, 1994, Alpha particle emitting constructs of recombinant humanized anti-CD33 for myeloid leukemias, 35, 648 Patridge, 1994, Phase I study of intraperitoneal lutetium-177 (Lu-177) monoclonal CC49 for ovarian cancer, 35, 505 Queen, 1989, A humanized antibody that binds to the interleukin 2 receptor, 86, 10029 Riechmann, 1988, Reshaping human antibodies for therapy, Nature, 332, 323, 10.1038/332323a0 Schlom, 1991, Monoclonal antibody-based therapy of human tumor xenograft with a 177-lutetium-labeled immunoconjugate, Cancer Res., 51, 2889 Schwartz, 1993, Doseescalation trial of M195 labeled with iodine 131 for cytoreduction and marrow ablation in relapsed or refractory myeloid leukemias, J. clin. Oncol., 11, 294, 10.1200/JCO.1993.11.2.294 Tanimoto, 1989, Restricted expression of an early myeloid and monocytic cell surface antigen defined by monoclonal antibody M195, Leukemia, 3, 339 Winnard, 1994, Improving the direct labeling of antibodies with Re-188, J. nucl. Med., 35, 260 Zalutsky, 1987, A method for the radiohalogenation of proteins resulting in decreased thyroid uptake of radioiodine, Appl. Radiat. Isotopes, 38, 1051, 10.1016/0883-2889(87)90069-4